Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Ruepp

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Mutation Research|June 1, 2005
Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?Anke Lühe, Laura Suter, Stefan Ruepp, et al.
Environmental Health Perspectives|September 4, 2004
Discriminating different classes of toxicants by transcript profilingGuido Steiner, Laura Suter, Franziska Boess, et al.
Toxicology and Applied Pharmacology|July 2, 2005
Assessment of hepatotoxic liabilities by transcript profilingStefan Ruepp, Franziska Boess, Laura Suter, et al.
Journal of Pharmacological and Toxicological Methods|December 17, 2018
Assessing the risk of drug crystallization in vivoStefan Ruepp, Evan Janovitz, Thomas Brodie, et al.
Molecular & Cellular Proteomics : MCP|May 18, 2006
Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in ratHélène Meistermann, Jeremy L Norris, Hans-Rudolf Aerni, et al.
ACS Medicinal Chemistry Letters|May 19, 2022
Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)Ratna Kumar Sreekantha, Christopher P Mussari, Dharmpal S Dodd, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2016
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitorsRajeev S Bhide, James Neels, Lan-Ying Qin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2016
Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing ActivityShailesh Dudhgaonkar, Sourabh Ranade, Jignesh Nagar, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2017
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitorsLan-Ying Qin, Zheming Ruan, Robert J Cherney, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Mutation Research|June 1, 2005
Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?Anke Lühe, Laura Suter, Stefan Ruepp, et al.
Environmental Health Perspectives|September 4, 2004
Discriminating different classes of toxicants by transcript profilingGuido Steiner, Laura Suter, Franziska Boess, et al.
Toxicology and Applied Pharmacology|July 2, 2005
Assessment of hepatotoxic liabilities by transcript profilingStefan Ruepp, Franziska Boess, Laura Suter, et al.
Journal of Pharmacological and Toxicological Methods|December 17, 2018
Assessing the risk of drug crystallization in vivoStefan Ruepp, Evan Janovitz, Thomas Brodie, et al.
Molecular & Cellular Proteomics : MCP|May 18, 2006
Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in ratHélène Meistermann, Jeremy L Norris, Hans-Rudolf Aerni, et al.
ACS Medicinal Chemistry Letters|May 19, 2022
Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)Ratna Kumar Sreekantha, Christopher P Mussari, Dharmpal S Dodd, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)Christopher P Mussari, Dharmpal S Dodd, Ratna Kumar Sreekantha, et al.
Bioorganic & Medicinal Chemistry Letters|August 2, 2016
Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitorsRajeev S Bhide, James Neels, Lan-Ying Qin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2016
Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing ActivityShailesh Dudhgaonkar, Sourabh Ranade, Jignesh Nagar, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2017
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitorsLan-Ying Qin, Zheming Ruan, Robert J Cherney, et al.
Pageof 2